DRMA Dermata Therapeutics, Inc. - Common Stock
$1.16
Price · May 20, 2026
52W Range
$1–$8
1% of range
Analyst Rating
BUY
7 analysts
Price Target
$4
+245% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
DRMA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.16
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $8
DRMA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DRMA
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DRMA
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DRMA
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DRMA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DRMA
Peer Median
DRMA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-05-18
Low
$4.00
High
$4.00
Median target
$4.00
+244.8%
Mean target
$4.00
+244.8%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.64%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.48 | $-0.54 | 0.06% |
| Dec. 31, 2025 | $-1.52 | $-1.57 | 0.05% |
| Sept. 30, 2025 | $-1.65 | $-1.62 | -0.03% |
| June 30, 2025 | $-1.66 | $-2.96 | 1.3% |
| March 31, 2025 | $-4.50 | $-4.59 | 0.09% |
| Dec. 31, 2024 | $-20.60 | $-15.30 | -5.3% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DRMA | — | — | — | — | — | — |
| SNGX | $14M | -0.6 | -85.8% | — | -311.2% | — |
| AQB | $4M | -0.2 | -21.2% | — | -315.5% | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| AKTX | $26.17B | — | — | — | -64.1% | — |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.